Pan W, Tsokos M, Li W, Tsokos G
Immunometabolism (Cobham). 2025; 7(1):e00056.
PMID: 39944077
PMC: 11812671.
DOI: 10.1097/IN9.0000000000000056.
Liu Q, Liu Y, Feng H, Zhao L, Wan T
Clin Rheumatol. 2024; 44(1):193-205.
PMID: 39126578
DOI: 10.1007/s10067-024-07094-0.
Zhou X, Li M, Ai M, Li Y, Zhu X, Hansen M
Eur J Immunol. 2024; 54(10):e2451080.
PMID: 39072720
PMC: 11550909.
DOI: 10.1002/eji.202451080.
Pan W, Tsokos M, Scherlinger M, Li W, Tsokos G
Cell Rep. 2024; 43(7):114379.
PMID: 38889006
PMC: 11414414.
DOI: 10.1016/j.celrep.2024.114379.
Huang L, Zuo Y, Yang H, He X, Zhang L
Front Neurol. 2024; 14:1334131.
PMID: 38384322
PMC: 10879883.
DOI: 10.3389/fneur.2023.1334131.
PP2A catalytic subunit alpha is critically required for CD8 T cell homeostasis and anti-bacterial responses.
Zhou X, Li M, Ai M, Li Y, Zhu X, Hansen M
bioRxiv. 2024; .
PMID: 38370780
PMC: 10871277.
DOI: 10.1101/2024.02.06.578745.
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus.
Lanata C, Taylor K, Hurst-Hopf J, Nititham J, Blazer A, Trupin L
Arthritis Rheumatol. 2023; 76(6):905-918.
PMID: 38129991
PMC: 11136608.
DOI: 10.1002/art.42779.
Protein Phosphatase 2A Activation Promotes Heart Transplant Acceptance in Mice.
Zhou X, Xu Q, Li W, Dong N, Stomberski C, Narla G
Transplantation. 2023; 108(3):e36-e48.
PMID: 38126420
PMC: 10922415.
DOI: 10.1097/TP.0000000000004832.
Putting a Novel Emphysema Treatment on the SMAP.
Xing D, Wells J
Am J Respir Cell Mol Biol. 2023; 69(5):491-492.
PMID: 37552790
PMC: 10633842.
DOI: 10.1165/rcmb.2023-0263ED.
Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4 T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus.
Park J, Perl A
Int J Mol Sci. 2023; 24(13).
PMID: 37445926
PMC: 10341602.
DOI: 10.3390/ijms241310749.
Protein Phosphatase 2A: Role in T Cells and Diseases.
Roy S, Batra L
J Immunol Res. 2023; 2023:4522053.
PMID: 37234102
PMC: 10208765.
DOI: 10.1155/2023/4522053.
Protein phosphatase 2A propels follicular T helper cell development in lupus.
Jiang Y, Jin X, Chi Z, Bai Y, Manthiram K, Mudd P
J Autoimmun. 2023; 136:103028.
PMID: 37001432
PMC: 10327577.
DOI: 10.1016/j.jaut.2023.103028.
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford S, Bottini N
Nat Rev Drug Discov. 2023; 22(4):273-294.
PMID: 36693907
PMC: 9872771.
DOI: 10.1038/s41573-022-00618-w.
The star target in SLE: IL-17.
Yang Y, Yan C, Yu L, Zhang X, Shang J, Fan J
Inflamm Res. 2022; 72(2):313-328.
PMID: 36538077
DOI: 10.1007/s00011-022-01674-z.
Sex-based comparison of CD4+ T cell DNA methylation in lupus reveals proinflammatory epigenetic changes in men.
Ali M, Coit P, Sawalha A
Clin Immunol. 2022; 243:109116.
PMID: 36075396
PMC: 10236946.
DOI: 10.1016/j.clim.2022.109116.
PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
Pan W, Scherlinger M, Yoshida N, Tsokos M, Tsokos G
J Immunol. 2022; 209(3):621-628.
PMID: 35831019
PMC: 9339485.
DOI: 10.4049/jimmunol.2200041.
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.
Pan J, Zhou L, Zhang C, Xu Q, Sun Y
Signal Transduct Target Ther. 2022; 7(1):177.
PMID: 35665742
PMC: 9166240.
DOI: 10.1038/s41392-022-01038-3.
Regulatory T Cells in Autoimmune Vasculitis.
Jin K, Parreau S, Warrington K, Koster M, Berry G, Goronzy J
Front Immunol. 2022; 13:844300.
PMID: 35296082
PMC: 8918523.
DOI: 10.3389/fimmu.2022.844300.
Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism.
Li W, Gong M, Park Y, Elshikha A, Choi S, Brown J
JCI Insight. 2021; 6(14).
PMID: 34156979
PMC: 8410062.
DOI: 10.1172/jci.insight.143540.
Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells.
Khan M, Valikangas T, Khan M, Moulder R, Ullah U, Bhosale S
Curr Res Immunol. 2021; 1:10-22.
PMID: 33817627
PMC: 8008788.
DOI: 10.1016/j.crimmu.2020.02.001.